Abstract
Caprolactam urea 1, identified as a weak Factor Xa inhibitor screening hit (IC50 = 16 μM), served as the starting point for a limited parallel-synthesis driven SAR study to improve potency. Remarkably, the corresponding thiourea analog 8c (IC50 = 0.11 μM) was 145-fold more potent against Factor Xa compared to 1. In general, caprolactam analogs containing a thiourea linker were significantly more potent than their corresponding urea counterparts, and it is hypothesized that this is partly due to a conformational preference of the thiourea linkage which facilitates binding of the terminal groups of the inhibitors to the Factor Xa S1/S4 pockets. Analog 8c was selective against a panel of related serine proteases. Upon intra-duodenal administration in rats, 8c dose-dependently increased prothrombin time ex vivo, and when dosed i.v., it demonstrated efficacy in a rat model of venous thrombosis. This thiourea lead series formed the basis for follow-on investigations to discover potent drug-like Factor Xa inhibitors using the caprolactam scaffold but employing suitable thiourea surrogates.
Keywords: Factor Xa, FXa inhibitor, caprolactam, serine protease
Letters in Drug Design & Discovery
Title: Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification
Volume: 2 Issue: 8
Author(s): Gregory S. Bisacchi, Philip D. Stein, Jack Z. Gougoutas, Karen S. Hartl, R. Michael Lawrence, Eddie Liu, Andrew Pudzianowski, William A. Schumacher, Doree Sitkoff, Thomas E. Steinbacher, James Sutton, Zhaoxiao Zhang and Steven M. Seiler
Affiliation:
Keywords: Factor Xa, FXa inhibitor, caprolactam, serine protease
Abstract: Caprolactam urea 1, identified as a weak Factor Xa inhibitor screening hit (IC50 = 16 μM), served as the starting point for a limited parallel-synthesis driven SAR study to improve potency. Remarkably, the corresponding thiourea analog 8c (IC50 = 0.11 μM) was 145-fold more potent against Factor Xa compared to 1. In general, caprolactam analogs containing a thiourea linker were significantly more potent than their corresponding urea counterparts, and it is hypothesized that this is partly due to a conformational preference of the thiourea linkage which facilitates binding of the terminal groups of the inhibitors to the Factor Xa S1/S4 pockets. Analog 8c was selective against a panel of related serine proteases. Upon intra-duodenal administration in rats, 8c dose-dependently increased prothrombin time ex vivo, and when dosed i.v., it demonstrated efficacy in a rat model of venous thrombosis. This thiourea lead series formed the basis for follow-on investigations to discover potent drug-like Factor Xa inhibitors using the caprolactam scaffold but employing suitable thiourea surrogates.
Export Options
About this article
Cite this article as:
Bisacchi S. Gregory, Stein D. Philip, Gougoutas Z. Jack, Hartl S. Karen, Lawrence Michael R., Liu Eddie, Pudzianowski Andrew, Schumacher A. William, Sitkoff Doree, Steinbacher E. Thomas, Sutton James, Zhang Zhaoxiao and M. Seiler Steven, Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification, Letters in Drug Design & Discovery 2005; 2 (8) . https://dx.doi.org/10.2174/157018005774717316
DOI https://dx.doi.org/10.2174/157018005774717316 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Click Reactions in Chemistry of Triterpenes - Advances Towards Development of Potential Therapeutics
Current Medicinal Chemistry Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer
Current Medicinal Chemistry Caspase Inhibitors: A Pharmaceutical Industry Perspective
Current Topics in Medicinal Chemistry Pyranoid Spirosugars as Enzyme Inhibitors
Current Organic Synthesis Diabetes and the Impairment of Reproductive Function: Possible Role of Mitochondria and Reactive Oxygen Species
Current Diabetes Reviews Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN)
Coronaviruses Bio Fabrication of Silver Nanoparticle from Argemone mexicana for the Control of Aedes albopictus and their Antimicrobial Activity
Current Pharmaceutical Biotechnology Why has Cerium (III) Triflate been Forgotten Among the Catalysts for the Friedel-Crafts Acylation?
Letters in Organic Chemistry The Roles of Vitamin D in Increasing the Body's Immunity and Reducing Injuries due to Viral Infections: With an Emphasis on its Possible Role in SARS-CoV-2 (COVID-19)
Current Pharmaceutical Design Design and Development of a Hardware Efficient Image Compression Improvement Framework
Micro and Nanosystems On Various Metrics Used for Validation of Predictive QSAR Models with Applications in Virtual Screening and Focused Library Design
Combinatorial Chemistry & High Throughput Screening Building Nanoscale Architectures by Directed Synthesis and Self-Assembly
Current Nanoscience Applications of Indan-1,3-Dione in Heterocyclic Synthesis
Current Organic Synthesis Aminophosphonate Metal Complexes of Biomedical Potential
Current Medicinal Chemistry Targeting Virus-Induced Reprogrammed Cell Metabolism <i>via</i> Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2
Mini-Reviews in Medicinal Chemistry G9a - An Appealing Antineoplastic Target
Current Cancer Drug Targets Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry QSAR and Complex Network Recognition of miRNAs in Stem Cells
Current Bioinformatics Molecular Symmetry: A Structural Property Frequently Present in New Cytotoxic and Proapoptotic Drugs
Mini-Reviews in Medicinal Chemistry The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets